Department of Bioengineering and Therapeutic Sciences

In clinical work and discovery science, the School takes on COVID-19

Tue May 12, 2020
The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.

Update from the Dean: Eyeing a return

Fri May 8, 2020
Guglielmo
Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: Dean Guglielmo provides an update on School activities and a careful return to campus

Respiratory infections may drive Puerto Rico’s high asthma burden

Thu May 7, 2020

UCSF team has discovered drugs that block coronavirus, paving way for ‘a better drug sooner’

Thu May 7, 2020

Update from the Dean: Looking forward to recovery

Fri Apr 24, 2020
Guglielmo
Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: How COVID-19 is affecting us and where to find updates.

Overcoming disease with moving pictures and molecular building blocks

Mon Apr 13, 2020
Fraser
Elisabeth Fall

Jaime Fraser, PhD

Jaime Fraser delivered the 2020 Byers Award Lecture in Basic Science

Update from the Dean: We are rising to the challenges presented by COVID-19

Fri Apr 10, 2020
Guglielmo
Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: We are rising to the challenges presented by COVID-19.

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

Thu Apr 2, 2020
Ahituv and Inoue
Susan Merrell

Nadav Ahituv, PhD, right, with postdoctoral scholar Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

Personal Protective Equipment (PPE) Collection

Wed Apr 1, 2020
goggles, face mask, glove, heart.
UCSF School of Pharmacy PharmD students are helping Bay Area hospitals with their PPE (personal protective equipment) shortages by collecting personal protective equipment.

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020
SARS-COV2 virus particles on human cells
NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue).

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Pages